S-1/A: Origin Investment Corp I Files Amended S-1 for $60M SPAC IPO Targeting Asia's High-Growth Sectors

Origin Investment Corp I, a newly formed blank check company, filed an amended S-1 registration statement for an initial public offering of 6,000,000 units at $10.00 each, aiming to acquire businesses in Asia's financial services, technology, biotechnology & pharmaceutical, advanced materials, and clean energy sectors.

Summary

• Origin Investment Corp I is a blank check company incorporated on September 25, 2024, in the Cayman Islands, with no operating history or revenues to date.
• The company plans an initial public offering of 6,000,000 units at $10.00 per unit, each unit comprising one ordinary share and one-half of one redeemable warrant.
• Underwriters have a 45-day option to purchase up to an additional 900,000 units to cover over-allotments.
• Origin Equity LLC, the sponsor, will concurrently purchase 355,000 private units (or up to 373,000 if the over-allotment option is fully exercised) at $10.00 per unit, totaling $3,550,000.
• The company intends to focus its search for an initial business combination on private companies in Asia, specifically in Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy sectors.
• A total of $60,600,000 (or $69,690,000 if the over-allotment option is fully exercised) from the offering proceeds and private placement will be deposited into a trust account, to be invested in U.S. government treasury bills or money market funds.
• The company must complete its initial business combination within 24 months from the closing of the offering, or it will redeem all public shares.
• Public shareholders will have the opportunity to redeem their shares at a per-share price, payable in cash, equal to the pro rata amount then on deposit in the trust account (anticipated to be $10.10 per share), less income taxes payable.
• The sponsor's 1,725,000 founder shares, acquired for a nominal $25,000 (approximately $0.014 per share), and private units will become worthless if an initial business combination is not completed.
• Public shareholders will experience an immediate and material dilution of approximately 110.30% (or $11.03 per share, assuming no value is ascribed to the warrants and maximum redemption) upon the closing of this offering.
• As of October 15, 2024, the company reported a net tangible book value deficit of $186,724, or approximately $(0.11) per ordinary share.

Sentiment

Score: 6

Explanation: The filing presents a standard SPAC offering with an experienced management team and a clear strategic focus on high-growth Asian sectors, which are positive attributes. However, the inherent risks of SPACs, including significant dilution for public shareholders, potential conflicts of interest, and the strict timeline for a business combination, temper the overall sentiment. The detailed disclosure of these risks is transparent but underscores the speculative nature of the investment.

Positives

• The management team and board of directors possess extensive experience in financial services, mergers and acquisitions, and operating public companies, which is crucial for identifying and executing a business combination.
• The company benefits from an established deal sourcing network, including industry executives, private equity funds, and investment bankers, expected to provide high-quality acquisition opportunities.
• The SPAC structure offers target businesses a potentially more cost-effective and certain alternative to a traditional initial public offering, providing access to U.S. public capital markets.
• The strategic focus on high-growth industries in Asia, such as Financial Services (driven by AI, blockchain), Technology (outperforming S&P 500 in 2023), Biotechnology & Pharmaceutical (active M&A market), Advanced Materials (8.2% CAGR to $582.3 billion by 2030), and Clean Energy (50% investment increase from 2019-2023), aligns with significant market opportunities.
• Asian emerging market and developing economies are projected to expand 5.2% in 2024, outpacing overall global growth of 3.2%, indicating a favorable regional economic backdrop for target acquisitions.

Negatives

• The company is a blank check company with no operating history, revenues, or specific target identified, making it a highly speculative investment.
• Public shareholders will incur immediate and material dilution (approximately 110.30% or $11.03 per share) due to the sponsor's acquisition of founder shares at a nominal price ($0.014 per share).
• Significant potential conflicts of interest exist for the sponsor, officers, and directors due to their substantial financial incentives (founder shares, private units, monthly administrative fees, convertible loans) and other business affiliations.
• Public shareholders may not have the opportunity to vote on the proposed business combination, and even if a vote is held, the sponsor's voting power (20% of outstanding shares) increases the likelihood of approval.
• High redemption rates by public shareholders could reduce the cash available for a business combination, making the company less attractive to potential targets or limiting the most desirable transactions.
• The 24-month deadline to complete a business combination may give potential target businesses leverage in negotiations and limit the time for thorough due diligence.
• The company faces significant competition from other SPACs, private equity firms, and operating businesses for attractive acquisition targets, potentially increasing acquisition costs.
• There is a risk of being deemed an investment company under the Investment Company Act, which could impose burdensome compliance requirements or force liquidation.
• A U.S. federal excise tax could be imposed on redemptions if the company domesticates to a U.S. corporation in connection with a business combination, reducing cash available for redemptions or impacting remaining shareholders.
• The U.S. federal income tax consequences for investors are uncertain, particularly regarding unit allocation, cashless warrant exercise, and PFIC rules.
• Warrants may be redeemed by the company prior to their expiration at a disadvantageous time for holders, potentially rendering them worthless.
• The terms of the warrants can be amended in a manner adverse to public warrant holders with the approval of only 50% of outstanding public warrants.
• The company's ability to assess the management of a prospective target business may be limited, potentially leading to issues with operating a public company post-combination.
• There is a risk of substantial write-downs, write-offs, or other charges post-business combination if due diligence fails to identify all material issues or unexpected factors arise.

Risks

• We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
• Our public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares will participate in such vote, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination.
• Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.
• Our sponsor will control the appointment of our board of directors until consummation of our initial business combination and will hold a substantial interest in us. As a result, it will appoint all of our directors prior to the consummation of our initial business combination and may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support.
• If we seek shareholder approval of our initial business combination, our initial shareholders and management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
• The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
• The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares and the amount of deferred underwriting compensation may not allow us to complete the most desirable business combination or optimize our capital structure, and may substantially dilute your investment in us.
• The requirement that we complete our initial business combination within 24 months may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.
• If we seek shareholder approval of our initial business combination, our sponsor, initial shareholders, directors, officers and their affiliates may elect to purchase shares or public warrants from public shareholders, which may influence a vote on a proposed business combination and reduce the public float of our ordinary shares or public warrants.
• If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for submitting or tendering its shares, such shares may not be redeemed.
• Our officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.
• You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
• NASDAQ may delist our securities from trading on its exchange, which could limit investors ability to make transactions in our securities and subject us to additional trading restrictions.
• The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.
• The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary at such time is substantially less than $10.00 per share.
• You will not be entitled to protections normally afforded to investors of many other blank check companies.
• Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination, our public shareholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and our warrants will expire worthless.
• If the net proceeds of this offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for at least 24 months, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or our management team to fund our search and to complete our initial business combination.
• Past performance by our management team, our advisors and their respective affiliates, including investments and transactions in which they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment in the company.
• We may be a passive foreign investment company, or PFIC, which could result in adverse United States federal income tax consequences to U.S. investors.
• To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the trust account, we may, at any time (based on our management teams ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank until the earlier of the consummation of our initial business combination or our liquidation. As a result, following the liquidation of investments in the trust account, we would likely receive less interest on the funds held in the trust account, which would likely reduce the dollar amount our public shareholders would receive upon any redemption or liquidation.
• If our initial business combination involves a company organized under the laws of the United States (or any subdivision thereof), a U.S. federal excise tax could be imposed on us in connection with any redemptions of our ordinary shares after or in connection with such initial business combination.
• If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.
• Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.
• Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the continued effects of the coronavirus (COVID-19) pandemic and the status of debt and equity markets, as well as protectionist legislation in our target markets.
• Our search for an initial business combination, and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected by current global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of conflict in the Middle East and Southwest Asia.
• Military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial condition of potential target companies, which could make it more difficult for us to consummate an initial business combination.
• We may reincorporate in or transfer by way of continuation to another jurisdiction which may result in taxes imposed on shareholders or warrant holders.
• An investment in this offering may result in uncertain U.S. federal income tax consequences.
• As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets or such attractive targets may not be interested to consummate a business combination with a SPAC due to a negative public perception of mergers involving SPACs. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
• Our initial business combination and our structure thereafter may not be tax-efficient to our shareholders and warrant holders. As a result of our business combination, our tax obligations may be more complex, burdensome and/or uncertain.

Future Outlook

The company anticipates generating non-operating income from interest earned on funds held in the trust account. It expects increased expenses as a public company, particularly for legal, financial reporting, accounting, auditing compliance, and due diligence. The primary strategic objective is to identify and complete an initial business combination within 24 months, focusing on high-growth sectors in Asia, and leveraging its management team's expertise and network to access U.S. public capital markets for target businesses.

Management Comments

• We believe our management team is well positioned to identify opportunities offering attractive risk-adjusted returns and that our professional contacts and transaction sources, ranging from industry executives, private owners, private equity funds, family offices, commercial and investment bankers, lawyers and other financial sector service providers and participants, in addition to the geographical reach of our management team and their affiliates, will enable us to pursue a broad range of opportunities.
• We believe that we will be an attractive initial business combination partner to prospective target businesses. As a publicly listed company, we will offer a target business an alternative to the traditional initial public offering process.
• We believe that the technological breakthroughs-including generative AI, blockchain, cloud migration, and cybersecurity enhancement-will open up new strategic opportunities [in the Financial Services sector].
• Pivotal and continuous advancements in AI have created compelling investment opportunities and are expected to fuel long-term sector growth [in the Technology sector].
• We believe that the dynamics suggest extensive business combination opportunities [in the Biotechnology & Pharmaceutical industry].
• The Asia-Pacific region is anticipated to lead the growth [in the Advanced Materials market], attributed to the high concentration of manufacturers and robust industrial activities within the area.
• The shift towards sustainable energy sources is accelerating the growth of the clean energy sector.
• Our team has extensive network, industry expertise, and proven deal-sourcing capabilities in these industries, which will provide us with a strong and differentiated pipeline of potential targets.
• Our management team intends to focus on creating shareholder value by leveraging its experience in the management, operation, and financing of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions.

Industry Context

The filing highlights a challenging IPO market in Asia Pacific in 2023, with IPO proceeds dropping 33% and private equity exits through IPOs significantly lower than the five-year average. This market condition positions de-SPAC transactions as an attractive alternative for private companies in Asia seeking access to U.S. public capital markets. The company's focus on high-growth sectors like Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy aligns with global trends of technological transformation, increased investment, and accelerated growth in these areas, particularly within the expanding Asian emerging markets.

Comparison to Industry Standards

• Asian emerging market and developing economies are expected to expand 5.2% in 2024, which is significantly higher than the 3.2% projected for overall global growth (International Monetary Fund).
• Asia Pacific IPO proceeds dropped 33% in 2023, and private equity exits through IPOs represented only 13% of total PE exits, compared to approximately 22% over the past five years (Deloitte).
• The technology sector outperformed the S&P 500 in 2023 and continued its strong performance into the first half of 2024, indicating robust sector-specific growth.
• The biopharma industry saw 1,256 total transactions across venture rounds, IPOs, licensing deals, and M&A in 2023 (JP Morgan), suggesting a dynamic market for business combinations.
• The global advanced materials market is projected to reach $582.3 billion revenue by 2030, growing at an 8.2% Compound Annual Growth Rate (P&S Intelligence), with Asia-Pacific leading this growth.
• Clean energy investment increased nearly 50% from 2019 to 2023, reaching $1.8 trillion in 2023 (International Energy Agency), with annual additions of solar PV and wind growing 85% and 60% respectively in 2023, demonstrating strong industry momentum.

Management Changes

Corporate Governance

Legal Proceedings

• No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacity as such.

Related Party Transactions

• Origin Equity LLC (sponsor) purchased 1,725,000 founder shares for an aggregate price of $25,000 (approximately $0.014 per share).
• The sponsor will purchase 355,000 private units (or up to 373,000 with over-allotment) at $10.00 per unit in a private placement concurrent with the IPO.
• The company will pay the sponsor $25,000 per month for office space, administrative, and support services, ceasing upon business combination completion or liquidation.
• The sponsor, officers, and directors, or their affiliates, will be reimbursed for out-of-pocket expenses incurred in identifying, investigating, and completing a business combination, with no specified cap.
• The sponsor loaned the company up to $500,000 for offering-related and organizational expenses, with $84,715 borrowed as of October 15, 2024.
• The sponsor or its affiliates, or certain officers and directors, may provide working capital loans up to $1,500,000, convertible into private units at $10.00 per unit at the lender's option.
• Potential payment of finders, advisory, consulting, or success fees to the sponsor, officers, directors, or their affiliates for services related to the business combination, payable from funds outside the trust account if prior to completion.

Stakeholder Impact

• Shareholders: Face immediate and material dilution from founder shares, have redemption rights for liquidity, but risk losing investment if no business combination is completed. May be subject to U.S. federal excise tax on redemptions if the company domesticates.
• Sponsor/Management: Stand to gain substantial profit from founder shares even if public shares decline, creating a strong incentive to complete a business combination. Receive monthly administrative fees and potential reimbursement for expenses and convertible loans.
• Target Businesses: Offered an alternative path to public listing (de-SPAC) potentially more cost-effective and certain than a traditional IPO, gaining access to broader capital sources and enhanced public profile.
• Creditors: Claims may take priority over public shareholders in the event of liquidation if the company fails to complete a business combination, potentially reducing the per-share redemption amount.

Next Steps

• Complete the initial public offering of 6,000,000 units.
• Apply to list units on NASDAQ under the symbol OIGPU, and subsequently ordinary shares (OIGP) and public warrants (OIGPW) for separate trading.
• File a Current Report on Form 8-K with the SEC promptly after the closing of the offering, including an audited balance sheet reflecting gross proceeds.
• Identify and consummate an initial business combination with one or more target businesses within 24 months from the closing of the offering.
• File a post-effective amendment to the registration statement or a new registration statement covering ordinary shares issuable upon warrant exercise within 15 business days after the initial business combination closing, and maintain its effectiveness.
• Establish and maintain an audit committee and a compensation committee of the board of directors.
• Adopt a Code of Ethics applicable to directors, officers, and employees.
• Comply with internal control requirements of the Sarbanes-Oxley Act, beginning with the first Annual Report on Form 10-K.

Key Dates

Recommendation

The company is a newly formed SPAC with no operational history or revenue, making it a highly speculative investment. While the experienced management team and focus on high-growth Asian sectors offer potential, the significant dilution for public shareholders, inherent conflicts of interest, and the strict 24-month deadline for a business combination introduce substantial risks. A 'hold' recommendation is appropriate for seasoned investors to observe the company's progress in identifying a suitable target and the specific terms of any proposed business combination before committing further capital or making a divestment decision.

Keywords

SPAC, Special Purpose Acquisition Company, IPO, Blank Check Company, Asia, Financial Services, Technology, Biotechnology, Pharmaceutical, Advanced Materials, Clean Energy, Merger, Acquisition, NASDAQ, OIGPU, OIGP, OIGPW, Origin Investment Corp I, SEC Filing, S-1/A